ProKidney
PROK

ProKidney (PROK) news

Recent news

Applied Optoelectronics files to offer $600M shares

Applied Optoelectronics Inc. (AAOI) has drawn attention amid recent market activity involving a $600 million trading volume tied to eBay (EBAY), though AAOI itself has not filed for a new share offering as of this writing. The company reported a net loss of $2.0 million for Q4 2025 , representing…

AInvest Wire · May 14, 2026

Prokidney focused Co. resources on Proact 1

Prokidney focused Co. resources on Proact 1 Prokidney Corp. (PROK), a pioneering late-stage cellular therapeutics company specializing in chronic kidney disease (CKD), has recently announced updated positive interim data from its RMCL-002 Phase 2 study [1]. These encouraging results support the…

AInvest Wire · Sep 3, 2024

ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering ProKidney Corp. (PROK), a pioneering late-clinical-stage cellular therapeutics company, recently announced plans for a proposed public offering of Class A ordinary shares…

AInvest Wire · Jun 10, 2024

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.